|
TCF12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.917740E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.563900E-04 |
| Normal-vs-Stage2 |
5.588000E-01 |
| Normal-vs-Stage3 |
5.273400E-01 |
| Normal-vs-Stage4 |
1.960190E-01 |
| Stage1-vs-Stage2 |
2.300600E-01 |
| Stage1-vs-Stage3 |
1.868370E-01 |
| Stage1-vs-Stage4 |
9.518200E-01 |
| Stage2-vs-Stage3 |
9.846600E-01 |
| Stage2-vs-Stage4 |
4.657600E-01 |
| Stage3-vs-Stage4 |
4.966800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.143100E-03 |
| Normal-vs-AfricanAmerican |
2.162300E-02 |
| Normal-vs-Asian |
5.062200E-01 |
| Caucasian-vs-AfricanAmerican |
9.384600E-01 |
| Caucasian-vs-Asian |
9.520200E-01 |
| AfricanAmerican-vs-Asian |
9.720400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.18709999999511E-05 |
| Normal-vs-Female |
7.890400E-01 |
| Male-vs-Female |
2.137100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.771180E-01 |
| Normal-vs-Extreme_Weight |
4.437800E-03 |
| Normal-vs-Obese |
4.304000E-02 |
| Normal-vs-Extreme_Obese |
4.344900E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.645600E-01 |
| Normal_Weight-vs-Obese |
9.310400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.684400E-01 |
| Extreme_Weight-vs-Obese |
3.618200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.903200E-01 |
| Obese-vs-Extreme_Obese |
3.010400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.612600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.520000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.34299999998699E-06 |
| Normal-vs-Age(81-100Yrs) |
6.032000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.320000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.248500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.458100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.223700E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.765850E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.534000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.757150E-03 |
| Normal-VS-Type2 PRCC |
5.391900E-02 |
| Normal-VS-KIRP CIMP |
2.939900E-02 |
| Normal-VS-Unclassified PRCC |
2.353400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.557400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.055400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.336200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.192600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.724200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.713800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.419600E-04 |
| Normal-vs-N1 |
7.192400E-01 |
| Normal-vs-N2 |
8.037600E-01 |
| N0-vs-N1 |
1.040000E-01 |
| N0-vs-N2 |
4.151200E-01 |
| N1-vs-N2 |
6.476400E-01 |
|
|
